Khurram Jamil, Chief Medical Officer at GALECTIN THERAPEUTICS INC (GALT), sold 52,037 shares at $5.00 ($262K) on 2026-06-26, disclosed to the SEC on 2026-06-30.
Scheduled sale ($262k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 2,037 | $10K | 3.9% |
| 2 | $5.00 | 2,533 | $13K | 4.8% |
| 3 | $5.04 | 47,467 | $239K | 91.3% |
| Total | $5.04 avg | 52,037 | $262K | 100% |
| Filing → |
| GALT | SELL | 2026-05-28 | $2K | — | Filing → |
| GALT | SELL | 2026-01-06 | $465K | — | Filing → |
| GALT | SELL | 2026-01-05 | $33K | — | Filing → |